Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

<p>Statistics from DESeq2</p>

Saved in:
Bibliographic Details
Main Author: Alyssa C. Flint (16676029) (author)
Other Authors: Dana K. Mitchell (16676032) (author), Steven P. Angus (15084264) (author), Abbi E. Smith (16676035) (author), Waylan Bessler (16676038) (author), Li Jiang (16676041) (author), Henry Mang (15293185) (author), Xiaohong Li (16676044) (author), Qingbo Lu (16676047) (author), Brooke Rodriguez (16676050) (author), George E. Sandusky (16676053) (author), Andi R. Masters (16676056) (author), Chi Zhang (15084270) (author), Pengtao Dang (16676059) (author), Jenna Koenig (16676062) (author), Gary L. Johnson (15081520) (author), Weihua Shen (16676065) (author), Jiangang Liu (15018711) (author), Amit Aggarwal (16610489) (author), Gregory P. Donoho (16676068) (author), Melinda D. Willard (16676071) (author), Shripad V. Bhagwat (16676074) (author), D. Wade Clapp (16676077) (author), Steven D. Rhodes (16676080) (author)
Published: 2025
Subjects:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Methods and Technology
Cell Cycle
CDKs and CDK inhibitors
Chemotherapy
Combination chemotherapy
Gene Technologies
High-throughput sequencing
Preclinical Models
Animal models of cancer
Proteomics
Rare Cancers
Translational Research
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items